Caspase-3 activity, response to chemotherapy and clinical outcome in patients with colon cancer

[1]  C. Rödel,et al.  Apoptosis as a cellular predictor for histopathologic response to neoadjuvant radiochemotherapy in patients with rectal cancer. , 2002, International journal of radiation oncology, biology, physics.

[2]  G. Rechkemmer,et al.  Contribution of apoptosis to responses in the comet assay. , 2001, Mutation research.

[3]  G. Fleuren,et al.  Caspase-3 activity as a prognostic factor in colorectal carcinoma. , 2001, Laboratory investigation; a journal of technical methods and pathology.

[4]  P J Catalano,et al.  Molecular predictors of survival after adjuvant chemotherapy for colon cancer. , 2001, The New England journal of medicine.

[5]  M. O’connell,et al.  New adjuvant therapy for colon cancer: justified hope or commercial hype. , 2000, Surgical oncology clinics of North America.

[6]  L. Butler,et al.  The activity of caspase-3-like proteases is elevated during the development of colorectal carcinoma. , 1999, Cancer letters.

[7]  H. Zhang,et al.  Apoptosis in relation to proliferating cell nuclear antigen and Dukes' stage in colorectal adenocarcinoma. , 1999, International journal of oncology.

[8]  F. Sinicrope,et al.  Apoptotic and mitotic indices predict survival rates in lymph node-negative colon carcinomas. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[9]  I. Talbot,et al.  Imbalance between proliferation and apoptosis in the development of colorectal carcinoma , 1998, Virchows Archiv.

[10]  D. Altieri,et al.  Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. , 1998, Cancer research.

[11]  T. Tsuruo,et al.  5-Fluorouracil induces apoptosis in human colon cancer cell lines with modulation of Bcl-2 family proteins. , 1998, British Journal of Cancer.

[12]  D. Chung.  Molecular prognostic markers and colorectal cancer: the search goes on. , 1998, Gastroenterology.

[13]  G M Cohen,et al.  Caspases: the executioners of apoptosis. , 1997, The Biochemical journal.

[14]  R. Ward,et al.  Pathological and genetic correlates of apoptosis in the progression of colorectal neoplasia. , 1997, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[15]  D. V. van Helden,et al.  The sigma receptor ligand, reduced haloperidol, induces apoptosis and increases intracellular-free calcium levels [Ca2+]i in colon and mammary adenocarcinoma cells. , 1996, Biochemical and biophysical research communications.

[16]  G. Baretton,et al.  Apoptosis and immunohistochemical bcl‐2 expression in colorectal adenomas and carcinomas: Aspects of carcinogenesis and prognostic significance , 1996, Cancer.

[17]  M. Saegusa,et al.  Apoptosis of colon cancers assessed by in situ DNA nick end‐labeling method , 1996, Pathology international.

[18]  P. Pasricha,et al.  Inhibition of apoptosis during development of colorectal cancer. , 1995, Cancer research.

[19]  C. Winterford,et al.  Apoptosis. Its significance in cancer and cancer Therapy , 1994, Cancer.

[20]  M. D’Incalci,et al.  Apoptosis Biochemical events and relevance to cancer chemotherapy , 1992, FEBS letters.

[21]  H. Hollema,et al.  Changes in apoptosis during the development of colorectal cancer: a systematic review of the literature. , 2003, Critical reviews in oncology/hematology.